EyePoint Pharmaceuticals Inc. buy Mizuho
Start price
17.02.24
/
50%
€26.60
Target price
17.02.25
€36.18
Performance (%)
-71.94%
Price
27.09.24
€7.21
Summary
This prediction is currently active. Massive losses of -71.94% have been the result for the BUY prediction by Mizuho. This prediction currently runs until 17.02.25. The prediction end date can be changed by Mizuho at any time. Mizuho has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
EyePoint Pharmaceuticals Inc. | -11.223% | -11.223% |
iShares Core DAX® | 3.523% | 3.763% |
iShares Nasdaq 100 | 1.026% | 2.380% |
iShares Nikkei 225® | -0.063% | 0.000% |
iShares S&P 500 | 0.557% | 2.222% |
Comments by Mizuho for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) had its price target raised by analysts at Mizuho from $30.00 to $39.00. They now have a "buy" rating on the stock.
Ratings data for EYPT provided by MarketBeat
Stopped prediction by Mizuho for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€9.92
07.05.24
07.05.24
€27.83
07.05.25
07.05.25
-24.73%
27.09.24
27.09.24
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€19.70
07.12.23
07.12.23
€27.74
07.12.24
07.12.24
-62.11%
27.09.24
27.09.24
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.00
02.11.23
02.11.23
€18.78
02.11.24
02.11.24
6.63%
27.09.24
27.09.24